InSight #Biopharmaceuticals Buys #Cancer #Treatment Company CureTech
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a deal to acquire cancer treatment company CureTech Ltd. The announcement was made Wednesday by Clal Biotechnology Industries, which holds 53% of CureTech’s shares. As [...]